Teva Pharmaceutical Industries

Teva Historical Price Chart

Teva Historical Price Chart

Teva Pharmaceutical Industries Ltd develops, produces and markets generic, branded & OTC medicines. Its products include Copaxone, Azilect and Provigil.

Website:  http://www.tevapharm.com

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. Its specialty medicines business focuses on delivering a range of solutions to patients and providers through medicines, devices and services in various regions and markets around the world. Its specialty medicines business includes its core therapeutic areas of central nervous system (CNS) and respiratory medicines with a focus on asthma and chronic obstructive pulmonary disease. It also has specialty products in oncology, women’s health and selected other areas.

Full Description

Teva Pharmaceutical Industries Limited, incorporated on February 13, 1944, is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. As of December 31, 2016, the Company had a global portfolio of over 1,800 molecules.

http://www.reuters.com/finance/stocks/companyProfile?rpc=66&symbol=TEVA.K

The Company competes with Biogen, Novartis AG, Genzyme, GlaxoSmithKline plc, Merck & Co. Inc., Sunovion, AstraZeneca plc, Chiesi, Allergan plc and Bayer AG.

Financial Summary

BRIEF: For the fiscal year ended 31 December 2016, Teva Pharmaceutical Industries Limited revenues increased 11% to $21.9B. Net income applicable to common stockholders decreased 96% to $68M. Revenues reflect Generic Madicines segment increase of 26% to $11.99B, Speciality Medicines segment increase of 4% to $8.67B, Rest of the World/Other segment increase of 38% to $4.85B, Europe segment increase of 11% to $5.41B.

[finviz ticker=TEVA]

Price update

30.76 +0.06 (0.20%)
Real-time: 11:09AM EDT
NYSE real-time data – Disclaimer
Currency in USD
Range 30.57 – 30.95
52 week 30.57 – 58.16
Open 30.76
Vol / Avg. 1.98M/5.56M
Mkt cap 31.22B
P/E 198.49
Div/yield 0.34/4.42
EPS 0.15
Shares 1.01B
Beta 0.63
Inst

Teva Pharmaceutical Industries Limited (TEVA) lost -3.61% to reach $30.99 in the previous trading session. Overall, 9.61 Million shares exchanged hands versus its average trading volume of 9.32 Million shares. The relative volume of the stock is 1.03, while its market cap is $31.59 Billion.

Relative Strength Index

The Relative Strength Index (RSI), developed by J. Welles Wilder, is a momentum oscillator that calculates the speed and change of price movements. The RSI oscillates between zero and 100. Usually the RSI is considered overbought when above 70 and oversold when less than 30.

Relative strength index (RSI-14) for Teva Pharmaceutical Industries Limited (TEVA) is at 27.97.

Teva Pharmaceutical Industries Limited shares decreased -4.68 percent over the past week and fell -7.88 percent over the previous month. The stock plunged -7.3 percent over the past quarter, while declined -26.51 percent over the past six months.

Anyway, as Ryan Fuhrmann, InvestorPlace Contributor, says in his article, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Double, the low earnings and cash flow valuation make the risk/reward tradeoff very appealing for Teva stock.

http://investorplace.com/2017/04/teva-pharmaceutical-industries-ltd-adr-teva-stock-double/#.WPjQzaIlGZI

Teva stock Nasdaq risk assessment

Teva stock Nasdaq risk assessment

Teva Pharmaceutical Industries Ltd (TEVA.N): Citigroup cuts target price to $42 from $47

TEVA: 5 years historical graph with some technical indicators

Teva 5 years historical graph with analysis

Teva 5 years historical graph with analysis

Teva historical dividends chart

Teva historical dividends chart

Salva

Salva

Salva

Salva

Salva

Salva

Salva

(Visited 59 times, 1 visits today)

About Carl William Brown

I'm Carl William Brown a holistic teacher, webmaster, trader, and writer of aphorisms and essays. I have written more than 10,000 original quotes and I'm working at my only novel, Fort Attack, which is also a wide and open blog project. At the moment I'm teaching English in a secondary school, but up to now I have done a lot of other things as well, both in business, education, sport and social fields. Some years ago, in 1997 following the examples of the Rotary and the Lyons I founded the Daimon Club Organization to promote every sort of social, artistic and financial creativity and to meet new friends with these kind of interests.
Tagged , , , , , , , , , , , , , , , . Bookmark the permalink.